{"organizations": [], "uuid": "fbe263d4b6aaf65444c5c7635430180a55232a38", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-syros-announces-new-preclinical-da/brief-syros-announces-new-preclinical-data-on-sy-1365-showing-potent-anti-tumor-activity-in-multiple-models-of-heavily-pretreated-ovarian-cancer-idUSFWN1RT0B1", "country": "US", "domain_rank": 408, "title": "BRIEF-Syros Announces New Preclinical Data On SY-1365 Showing Potent Anti-Tumor Activity In Multiple Models Of Heavily Pretreated Ovarian Cancer", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-16T15:02:00.000+03:00", "replies_count": 0, "uuid": "fbe263d4b6aaf65444c5c7635430180a55232a38"}, "author": "", "url": "https://www.reuters.com/article/brief-syros-announces-new-preclinical-da/brief-syros-announces-new-preclinical-data-on-sy-1365-showing-potent-anti-tumor-activity-in-multiple-models-of-heavily-pretreated-ovarian-cancer-idUSFWN1RT0B1", "ord_in_thread": 0, "title": "BRIEF-Syros Announces New Preclinical Data On SY-1365 Showing Potent Anti-Tumor Activity In Multiple Models Of Heavily Pretreated Ovarian Cancer", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "syros pharmaceuticals inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Market News April 16, 2018 / 12:03 PM / Updated 11 minutes ago BRIEF-Syros Announces New Preclinical Data On SY-1365 Showing Potent Anti-Tumor Activity In Multiple Models Of Heavily Pretreated Ovarian Cancer Reuters Staff 1 Min Read \nApril 16 (Reuters) - Syros Pharmaceuticals Inc: \n* SYROS ANNOUNCES NEW PRECLINICAL DATA ON SY-1365 SHOWING POTENT ANTI-TUMOR ACTIVITY IN MULTIPLE MODELS OF HEAVILY PRETREATED OVARIAN CANCER \n* SYROS PHARMACEUTICALS INC - ON TRACK TO REPORT DATA FROM DOSE ESCALATION PORTION OF PHASE 1 TRIAL IN Q4 OF 2018 \n* SYROS PHARMACEUTICALS INC - EXPECT TO OPEN EXPANSION COHORTS IN PHASE 1 TRIAL IN MID-2018 Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-16T15:02:00.000+03:00", "crawled": "2018-04-16T15:23:12.011+03:00", "highlightTitle": ""}